Endoskopie 2008; 17(3): 68-70

Role of endoscopy in diagnostic of Clostridum colitis

MUDr. Jiří Drábek
Interní klinika FN Motol, Praha

Colitis caused by Clostridum difficile is a possible complication of antimicrobial therapy. Clostridum difficile was described in literature

in 1935, but its importance is connected with the widespread of newer broad-spectrum antibiotics. Changes of intestine microflora and

subsequent production of toxins A and B by Clostridium difficile play the main role in ethiopathogenesis of the disease.

The diagnosis is based on the detection of toxins A and B, eventually on cultivation of Clostridium difficile and the proof of toxigenity

of particular tribe.

The role of endoscopy in diagnostic of this disease has been discussed.

In our work we proved in 29 % of patient’s pseudomembranous colitis, which is nearly always caused by Clostridium difficile. In 27 % of patients

we have diagnosed mild colitis, in 20 % of patients we diagnosed severe colitis without pseudomembranes. In 22 % of patients there

was a coincidence of ulcerative colitis and colitis caused by Clostridum difficile. Fulminant colitis has been diagnosed in one patient.

In our group of 49 patients with the diagnoses of Clostridium difficile related colitis, endoscopy was a good diagnostic method – that was

certainly carefully provided sigmoideoscopy without bowel preparation, when the material for toxin proof and cultivation was taken.

Keywords: endoscopy, Clostridium difficile, colitis.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drábek J. Role of endoscopy in diagnostic of Clostridum colitis. Endoskopie. 2008;17(3):68-70.
Download citation

References

  1. Elliot B, Chang BJ, Colledge CL, et al. Clostridium difficileassociated diarrhoea. Int. Med. J. 2007; 37: 561-568. Go to original source... Go to PubMed...
  2. Kelly CP, Poutholakis C, LaMont JT. Clostridium difficille Colitis. N. Engl. J.Med. 1994; 330(27): 257-262. Go to original source... Go to PubMed...
  3. Morris AM, Blair AJ, Stoney M, et al. Clostridium difficile Colitis. Arch. of Surg. 2002; 137: 1096-1100. Go to original source... Go to PubMed...
  4. Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and, foodborne disease? Clin. Microbiol. Infect. 2002; 13: 457-459. Go to original source... Go to PubMed...
  5. Barlett JG. Clostridium difficile: clinical considerations. Rev. Infect. Dis. 1990; 12: 243-251. Go to original source... Go to PubMed...
  6. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 2005; 18: 247-263. Go to original source... Go to PubMed...
  7. Barbut F, Decre D, Lalande V, et al. Clinical features of Clostridium difficile-associated diarhoea due to binary toxin. J. Med. Mircrobiol. 2005; 54: 181-185. Go to original source... Go to PubMed...
  8. Pepin J, Valiquette L, Alary ME, at al. Clostridium difficile associated diarrhoea in region of Quebec from 1991 to 2003, a changing pattern of disease Severiny. Can. Med. Assoc. J. 2004; 171: 466-472. Go to original source... Go to PubMed...
  9. Gerding DN, Johnson S. Clostridium difficile. In: Laser MJ, et al. Infections of the Gastrointestinal Tract, 2nd ed. Philadelphia 2002: 763-784.
  10. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile associated diarrhoea and collitis in adults: a prospective case-controlled epidemiologic study. Arch. Intern. Med. 1986; 146: 95-100. Go to original source... Go to PubMed...
  11. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990; 263(7): 979-982. Go to original source...
  12. LaMont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin durring relapse of chronic inflamatory bowel disease. Lancet. 1980; 23(1): 381-383. Go to original source... Go to PubMed...
  13. Bignardi GE. Risk factors for Clostridium difficile infection, J. Hosp. Infect. 1998; 40: 1-15. Go to original source... Go to PubMed...
  14. Kyne LM, Warny A, et al. Association between antibody response to toxin A and protection against reccurrent Clostridium difficile diarrhoea. Lancet 2001; 357: 189-193. Go to original source... Go to PubMed...
  15. Kyne LM, Warny M, et al. Asymptomatic carriage of Clostridium difficile and Serum Levels of IgG Antibody against toxin A. N. Engl. J. Med 2000; 342: 390-397. Go to original source... Go to PubMed...




Endoscopy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.